BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260115T200000
DTEND;TZID=America/Halifax:20260115T200000
DTSTAMP:20260405T134638
CREATED:20251130T152939Z
LAST-MODIFIED:20251130T153024Z
UID:10000427-1768507200-1768507200@oncodaily.com
SUMMARY:MASCC Webinar: ADCs and Mucositis: From Mechanism to Care
DESCRIPTION:The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15\, 2026\, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs)\, with a focus on the recognition\, prevention\, and management of ADC-induced oral mucositis. \nExpert speakers\, including Prof. Paolo Bossi\, Prof. Florian Scotté\, Dr. Barbara Pistilli\, Dr. Emmanuelle Vigarios\, and Dr. Helen Bulbeck\, will share clinical insights\, strategies for supportive care\, and the patient perspective on mucositis. This educational session is supported by an unrestricted grant from Daiichi Sankyo Europe. \nRegister here.
URL:https://oncodaily.com/event/mascc-418960
LOCATION:https://oncodaily.com/event/mascc-418960
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-2025-11-30T192911.269.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260115
DTEND;VALUE=DATE:20260116
DTSTAMP:20260405T134638
CREATED:20260106T214303Z
LAST-MODIFIED:20260106T214317Z
UID:10000560-1768435200-1768521599@oncodaily.com
SUMMARY:SEER-MHOS 2026 Update: Your Guide to the New Data Linkage
DESCRIPTION:The SEER-MHOS 2026 Update: Your Guide to the New Data Linkage is a specialized technical webinar hosted by the National Cancer Institute (NCI) Division of Cancer Control and Population Sciences. Scheduled for January 15\, 2026\, this session is designed for health services researchers\, epidemiologists\, and oncology professionals interested in leveraging large-scale data to study cancer survivorship. \nThe webinar focuses on the significant 2025 expansion of the Surveillance\, Epidemiology\, and End Results (SEER) and Medicare Health Outcomes Survey (MHOS) linkage. Key technical updates include the integration of data from 22 SEER registries and the debut of Medicare Advantage Encounter data\, which allows for a more granular analysis of where patients receive both oncology and non-oncology care. \nRegister.
URL:https://oncodaily.com/event/seer-mhos-2026-437625
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/NCI.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260114T123000
DTEND;TZID=America/Halifax:20260114T133000
DTSTAMP:20260405T134638
CREATED:20251218T150105Z
LAST-MODIFIED:20251218T150105Z
UID:10000509-1768393800-1768397400@oncodaily.com
SUMMARY:ANCO’s Medicare Regulations Update 2026
DESCRIPTION:The ANCO’s Medicare Regulations Update 2026 webinar on January 14\, 2026\, will provide a comprehensive overview of the latest Medicare changes affecting oncology services. \nBobbi Buell\, MBA\, will cover updates to the Physician Fee Schedule\, coding and billing\, evaluation and management\, and incentive programs\, offering essential insights for clinicians and practice teams. \nRegister here.
URL:https://oncodaily.com/event/anco-430538
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Annotation-2025-12-18-190040-Picsart-AiImageEnhancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260109
DTEND;VALUE=DATE:20260111
DTSTAMP:20260405T134638
CREATED:20251204T145833Z
LAST-MODIFIED:20251204T145906Z
UID:10000449-1767916800-1768089599@oncodaily.com
SUMMARY:2026 Highlights of ASH in North America
DESCRIPTION:The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person\, learn how to apply the latest research to their areas of expertise\, and gain insights into local and regional standards of care. In 2026\, the two-day program will be offered on four separate dates and locations: \n\nChicago\, Illinois | January 9-10\, 2026\nNew York\, New York | January 9-10\, 2026\nWashington\, D.C. | January 16-17\, 2026\nSeattle\, Washington | January 30-31\, 2026\n\nRegister.
URL:https://oncodaily.com/event/ash-in-north-america-421416
LOCATION:Co. Kildare
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Button-Play-66th-ASH-Annual-Meeting-and-Exposition-1.webp
ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260108T080000
DTEND;TZID=America/Halifax:20260110T170000
DTSTAMP:20260405T134638
CREATED:20250713T084301Z
LAST-MODIFIED:20250713T084336Z
UID:10000213-1767859200-1768064400@oncodaily.com
SUMMARY:ASCO Gastrointestinal Cancers Symposium 2026
DESCRIPTION:The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10\, 2026\, at Moscone West in San Francisco\, CA\, as well as online. \nThis annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment\, research\, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions\, the symposium offers a platform for clinicians\, researchers\, and industry experts to exchange insights and shape the future of gastrointestinal oncology. \nWith a focus on innovative science and solution-oriented strategies\, the symposium covers a broad range of GI cancers including colorectal\, pancreatic\, liver\, and esophageal cancers. Attendees can expect expert-led sessions\, abstract presentations\, and practical discussions on integrating new research into clinical practice.
URL:https://oncodaily.com/event/asco-328506
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/asco.jpg
ORGANIZER;CN="American Society of Clinical Oncology (ASCO) Direct":MAILTO:customerservice@asco.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251217T140000
DTEND;TZID=America/Halifax:20251217T150000
DTSTAMP:20260405T134638
CREATED:20251207T214247Z
LAST-MODIFIED:20251207T214307Z
UID:10000464-1765980000-1765983600@oncodaily.com
SUMMARY:Going Full TILt: Challenges\, Successes\, and Coordination with Administering TIL Therapy
DESCRIPTION:“Going Full TILt: challenges\, successes\, and coordination with administering TIL therapy” is an upcoming “Rx-cited: Clinical Conundrums” roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task Force\, scheduled for Wednesday\, December 17\, 2025\, from 2:00–3:00 PM CST. \nThe session is designed to be an informal Q&A discussion focusing on the challenges\, key points\, and future directions associated with offering Tumor Infiltrating Lymphocyte (TIL) therapy\, providing a space for both members and non-members working in transplantation and cellular therapy to connect and share insights on these latest advancements. \nRegister.
URL:https://oncodaily.com/event/going-full-tilt-423772
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ASTCT.webp
ORGANIZER;CN="American Society for Transplantation and Cellular Therapy (ASTCT)":MAILTO:info@astct.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251217T130000
DTEND;TZID=America/Halifax:20251217T141500
DTSTAMP:20260405T134638
CREATED:20251206T173920Z
LAST-MODIFIED:20251206T173950Z
UID:10000456-1765976400-1765980900@oncodaily.com
SUMMARY:SITC Webinar on Bispecifics and T Cell Engagers: Practical Strategies for Recognizing and Managing Toxicities
DESCRIPTION:The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual\, multi-stakeholder event scheduled for December 17\, 2025\, from 1:00 p.m. to 2:15 p.m. ET. The webinar will feature expert faculty\, including Sid Devarakonda\, MD\, and Megan May\, PharmD\, to provide clinical insights into the use of bispecifics and T cell engagers and the necessary management of their associated toxicity. \nThe primary focus is on identifying and employing best practices for treating immune-related adverse events (irAEs)\, particularly Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)\, with the goal of improving patient outcomes through multidisciplinary and collaborative approaches. \nRegister.
URL:https://oncodaily.com/event/bispecifics-and-t-cell-engagers-422941
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/sitc.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251217
DTEND;VALUE=DATE:20251218
DTSTAMP:20260405T134638
CREATED:20251203T223414Z
LAST-MODIFIED:20251203T223426Z
UID:10000436-1765929600-1766015999@oncodaily.com
SUMMARY:EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC
DESCRIPTION:The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17\, 2025\, at 18:00 CET. This free\, open-to-all online event will feature experts from medical oncology\, radiation oncology\, and thoracic surgery who will explore and discuss the status of current as well as upcoming clinical trials focused on the treatment of Stage III non-small cell lung cancer. \nRegister.
URL:https://oncodaily.com/event/eortc-421170
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/EORTC.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251216T200000
DTEND;TZID=America/Halifax:20251217T000000
DTSTAMP:20260405T134638
CREATED:20251109T181010Z
LAST-MODIFIED:20251109T181029Z
UID:10000330-1765915200-1765929600@oncodaily.com
SUMMARY:The State of AI in Precision Oncology 2025
DESCRIPTION:The State of AI in Precision Oncology 2025 is the third annual\, free virtual summit hosted by the journal AI in Precision Oncology\, aiming to assess the current evolution of medicine driven by Artificial Intelligence\, specifically within the field of oncology. \nScheduled for Tuesday\, Dec 16\, 2025 at 8:00 PM – Wednesday\, Dec 17\, 2025 at 12:00 AM (+04)\, the event features keynote interviews\, presentations\, and fireside chats with renowned experts like Amy Abernethy (former FDA executive)\, Isaac Kohane (Founding Editor of NEJM AI)\, and Connie Lehman (on AI in breast cancer screening). \nThe summit documents how clinicians are increasingly deploying AI applications and strategies to personalize treatments and transform their practice\, covering topics from blood-based cancer screening to the state of AI in community hospitals and a look ahead to “AI in Oncology 2030.”
URL:https://oncodaily.com/event/ai-in-precision-oncology-406089
LOCATION:Co. Kildare
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/AI-in-Precision-Oncology.jpg
ORGANIZER;CN="AI in Precision Oncology":MAILTO:AIPO_EO@liebertpub.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251216T130000
DTEND;TZID=America/Halifax:20251216T174000
DTSTAMP:20260405T134638
CREATED:20251031T222606Z
LAST-MODIFIED:20251031T222623Z
UID:10000305-1765890000-1765906800@oncodaily.com
SUMMARY:Digestive Oncology Autumn Symposium\, Edition 2025
DESCRIPTION:The Digestive Oncology Autumn Symposium\, Edition 2025\, is scheduled for the afternoon of Tuesday\, December 16\, 2025\, at Salons De Romree in Grimbergen\, Belgium. The event will begin with a lunch from 1:00 PM to 2:00 PM\, followed by the scientific presentations from 2:00 PM to 5:40 PM. This annual congress is presented by The Merck Medical Team and is a premier gathering for professionals interested in Antibody-Drug Conjugates (ADCs). \nThe symposium features a distinguished faculty of speakers and moderators\, including Professor Sabine Tejpar (UZ Leuven)\, Dr. Gertjan Rasschaert (UZ Leuven/ZAS Antwerpen)\, and Dr. Jochen Decaestecker (AZ Delta). They will be joined by international experts like Dr. Elizabeth Smyth (Oxford University\, UK) and Dr. Pia Österlund (Karolinska University Hospital\, Sweden). Attendees from over five countries will discuss the latest insights in digestive oncology. \nRegister.
URL:https://oncodaily.com/event/digestive-oncology-401430
LOCATION:Salons De Romree\, Beiaardlaan 31\, Grimbergen\, Flemish Brabant\, 1850\, Belgium
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/Screenshot-2025-11-01-021722.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251219
DTSTAMP:20260405T134638
CREATED:20251128T233427Z
LAST-MODIFIED:20251128T233443Z
UID:10000418-1765843200-1766102399@oncodaily.com
SUMMARY:1st National Oncology Nursing Conference
DESCRIPTION:The Oncology Nursing Society of Nigeria (ONSN) is hosting its 1st National Oncology Nursing Conference titled “Oncology Nursing in the Spotlight: Celebrating Excellence and Inspiring Growth.” \nThe conference is scheduled for December 16–18\, 2025\, at Babcock University in Ilishan Remo\, Ogun State\, Nigeria. \nThis landmark event aims to bring together over 500 local and international nursing leaders\, researchers\, clinicians\, and policymakers to strengthen cancer care delivery and workforce development across Nigeria and Africa. Attendees will gain actionable strategies for advancing oncology nursing practice\, policy\, and research.
URL:https://oncodaily.com/event/national-oncology-nursing-418154
LOCATION:Babcock University Ilishan Remo\, VPQ9+VPP\, Ilishan-Remo\, Ilishan-Remo\, Ogun State\, 121103\, Nigeria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/NONC.webp
ORGANIZER;CN="Oncology Nursing Society of Nigeria (ONSN)":MAILTO:info@onsnigeria.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251218
DTSTAMP:20260405T134638
CREATED:20251124T213007Z
LAST-MODIFIED:20251124T213103Z
UID:10000399-1765843200-1766015999@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2025: Lugano
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management\, from diagnosis to treatment\, according to current standards of care. \nOrganized by the European Society for Medical Oncology (ESMO)\, the event is scheduled to take place on December 16–17\, 2025\, in Lugano\, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists\, especially young oncologists\, and has been accredited for 9 ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-415823
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/1756803627507.jpeg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251213
DTEND;VALUE=DATE:20251215
DTSTAMP:20260405T134638
CREATED:20251124T212249Z
LAST-MODIFIED:20251124T212304Z
UID:10000398-1765584000-1765756799@oncodaily.com
SUMMARY:Best of ESMO India 2025
DESCRIPTION:The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai\, scheduled for December 13–14\, 2025. \nThis conference\, hosted by the Global Healthcare Academy (GHA)\, is a major platform for disseminating the most recent\, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress. \nDesigned for a multidisciplinary audience including medical\, surgical\, and radiation oncologists\, the event will feature focus sessions guided by an extensive advisory\, core\, and scientific committee comprising leading Indian oncologists\, and will be held at The St. Regis Mumbai. \nRegister.
URL:https://oncodaily.com/event/best-of-esmo-india-415818
LOCATION:The St. Regis Mumbai\, 462 Senapati Bapat Marg\, Lower Parel\, Mumbai\, Maharashtra\, 400013\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251213
DTSTAMP:20260405T134638
CREATED:20251128T234245Z
LAST-MODIFIED:20251128T234328Z
UID:10000419-1765411200-1765583999@oncodaily.com
SUMMARY:33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors
DESCRIPTION:The 33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors is a two-day scientific meeting organized by the TTD Group (Digestive Tumor Treatment Group). \nThe event will be held from December 11 to December 12\, 2025\, at the Exhibition and Congress Palace in Oviedo\, Spain. The symposium will feature presentations and discussions on the latest advances in treating various digestive tumors.
URL:https://oncodaily.com/event/international-ttd-symposium-418159
LOCATION:Oviedo Congress and Exhibitions Center\, C. Arturo Álvarez Buylla\, Oviedo\, Asturias\, 33005\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/170225_102024_1958259862.webp
ORGANIZER;CN="TTD Group (Digestive Tumor Treatment Group)":MAILTO:ttd@ttdgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
DTSTAMP:20260405T134638
CREATED:20251207T213917Z
LAST-MODIFIED:20251207T214051Z
UID:10000463-1765411200-1765497599@oncodaily.com
SUMMARY:BMT Across the World: Who Makes What and Who Pays Whom?
DESCRIPTION:“BMT Across the World: Who Makes What and Who Pays Whom?” is Part 1 of a joint educational series hosted by the ASTCT (American Society for Transplantation and Cellular Therapy) and the EBMT (European Society for Blood and Marrow Transplantation)\, scheduled for December 11\, 2025\, at 9:00 AM CST. \nFocusing on allogeneic Bone Marrow Transplantation (BMT)\, the session aims to explore the significant variations in the clinical\, logistical\, administrative\, and reimbursement landscapes for BMT therapies across different countries. Key topics include how BMT is regulated\, implemented\, and paid for globally\, alongside a critical appraisal of emerging innovations in areas such as GVHD prophylaxis\, conditioning regimens\, and relapse prevention. \nRegister.
URL:https://oncodaily.com/event/bmt-across-the-world-423766
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ASTCT.webp
ORGANIZER;CN="American Society for Transplantation and Cellular Therapy (ASTCT)":MAILTO:info@astct.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
DTSTAMP:20260405T134638
CREATED:20251129T232432Z
LAST-MODIFIED:20251129T232445Z
UID:10000425-1765411200-1765497599@oncodaily.com
SUMMARY:Advancing Pediatric ALL Care: Adapting Global Standards for LMICs
DESCRIPTION:The webinar “Advancing Pediatric ALL Care: Adapting Global Standards for LMICs“ will be held virtually on Thursday\, December 11\, 2025\, at 2 PM CET/Geneva. \nThis session focuses on sharing Global Updates and Future Directions in pediatric ALL care and specifically addressing how to translate and implement these advancements From Evidence to Practice in Resource-Limited Settings (LMICs)\, featuring a keynote presentation by Prof. Hiroto Inaba and experience-sharing from SIOP Asia Country Ambassadors. \nRegister.
URL:https://oncodaily.com/event/advancing-pediatric-all-care-418632
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ALL.webp
ORGANIZER;CN="International Society of Paediatric Oncology (SIOP)":MAILTO:info@siop-online.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
DTSTAMP:20260405T134638
CREATED:20251129T231515Z
LAST-MODIFIED:20251129T231525Z
UID:10000424-1765411200-1765497599@oncodaily.com
SUMMARY:The Role of Modern Radiotherapy for Low Grade Glioma
DESCRIPTION:The educational webinar titled “The Role of Modern Radiotherapy for Low Grade Glioma\,” part of the Educational Lectures on Paediatric Radiation Oncology Series\, will be held virtually on December 11\, 2025\, at 16:00 CET (Central European Time). \nThis open-to-all session will feature speaker Danny Indelicato\, Professor in the Department of Radiation Oncology at the University of Florida. The webinar will discuss how radiotherapy integrates into contemporary options for managing pediatric low-grade glioma. \nRegister.
URL:https://oncodaily.com/event/low-grade-glioma-418629
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/glioma.webp
ORGANIZER;CN="International Society of Paediatric Oncology (SIOP)":MAILTO:info@siop-online.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251210T083000
DTEND;TZID=America/Halifax:20251210T120000
DTSTAMP:20260405T134638
CREATED:20251206T001840Z
LAST-MODIFIED:20251206T001927Z
UID:10000455-1765355400-1765368000@oncodaily.com
SUMMARY:ESMO-IO SITC Primer Program
DESCRIPTION:The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC)\, scheduled for December 10\, 2025\, from 8:30 a.m. to 12:00 p.m. BST. \nThis half-day primer\, held at the Queen Elizabeth II Centre in London\, UK\, focuses on fundamental immuno-oncology (IO) concepts. \nThe program will cover current and emerging topics in immuno-oncology (IO)\, including neoadjuvant immunotherapy\, intratumoral immunotherapies\, recombinant cytokines\, and bispecific antibodies\, alongside new applications of AI\, spatial biology\, and multiomic approaches.
URL:https://oncodaily.com/event/esmo-422513
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMOSITC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20260405T134638
CREATED:20250701T130014Z
LAST-MODIFIED:20250701T130110Z
UID:10000206-1765353600-1765558800@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event\, both onsite in London\, UK\, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions\, in-depth learning opportunities\, and dynamic networking with peers\, researchers\, and industry leaders. \nThe programme includes immersion sessions focused on immunobiology and translational insights\, updates on checkpoint inhibitor-based therapies\, and the latest in immune modulation including tumour microenvironment\, immunometabolism\, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies\, cancer vaccines\, intratumoural immunotherapy\, and multispecific constructs. \nWhether attending in person or online\, the congress offers a valuable platform to share research\, expand knowledge\, and shape the future of cancer immunotherapy. \nRegistration is Open for the Event. \nMore posts featuring ESMO.
URL:https://oncodaily.com/event/esmo-immuno-oncology-congress-2025-321830
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_6227.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251214
DTSTAMP:20260405T134638
CREATED:20251128T234953Z
LAST-MODIFIED:20251128T235011Z
UID:10000420-1765324800-1765670399@oncodaily.com
SUMMARY:AOFOG-ASGO Gynecologic Oncology Research Workshop
DESCRIPTION:The AOFOG-ASGO Gynecologic Oncology Research Workshop (AGORE) is scheduled for December 10–13\, 2025\, and will be held at the Skycity Marriott in Hong Kong. \nThis event is specifically designed for gynecological oncology fellows and oncologists\, offering a unique opportunity to enhance their research skills through a program featuring engaging lectures\, mentoring sessions\, and hands-on workshops\, with the goal of advancing research expertise in the field. \nRegister.
URL:https://oncodaily.com/event/gynecologic-oncology-418164
LOCATION:Hong Kong SkyCity Marriott Hotel\, International Airport\, 1 Sky City Rd E\, Lantau Island\, Hong Kong\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/Screenshot-2025-11-29-034455.webp
ORGANIZER;CN="Asian Society of Gynecologic Oncology":MAILTO:adminoffice@asiansgo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251213
DTSTAMP:20260405T134638
CREATED:20251105T195850Z
LAST-MODIFIED:20251105T195909Z
UID:10000323-1765324800-1765583999@oncodaily.com
SUMMARY:Flash Radiotherapy and Particle Therapy 2025 Conference
DESCRIPTION:The FRPT (Flash Radiotherapy and Particle Therapy) 2025 Conference is a major multidisciplinary forum dedicated to uniting cutting-edge radiation therapies with groundbreaking research and clinical trials. The conference is scheduled for December 10–12\, 2025\, and will be held in Prague\, the Czech Republic. Over three days\, the event will showcase the latest updates on FLASH and particle therapy across basic science\, preclinical research\, clinical trials\, and treatment\, bringing together leading researchers\, clinicians\, industry providers\, and an international audience.
URL:https://oncodaily.com/event/flash-radiotherapy-403709
LOCATION:Clarion Congress Hotel Prague\, Freyova 945/33\, Prague\, Hlavni mesto Praha\, 190 00\, Czech Republic
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/475381440_577404905272763_6856074363405834217_n.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251211
DTSTAMP:20260405T134638
CREATED:20251207T213651Z
LAST-MODIFIED:20251207T213722Z
UID:10000462-1765324800-1765411199@oncodaily.com
SUMMARY:Assessing Physical Function in Transplantation and CAR T Recipients
DESCRIPTION:“Assessing Physical Function in Transplantation and CAR T Recipients” is a free panel-based webinar offered by the ASTCT Survivorship SIG (American Society for Transplantation and Cellular Therapy) and is scheduled for December 10\, 2025\, at 12:00 PM CST. \nThe webinar’s focus is on clinical practice and research\, aiming to help attendees identify and understand the currently available physical assessment tools for evaluating physical function in patients before\, during\, and after receiving hematopoietic cell transplantation (HCT) or CAR T-cell therapies. The expert panel includes speakers such as Shatha Farhan\, MD\, and Shernan Holtan\, MD\, and the goal is to bridge knowledge gaps and encourage the optimized use of these tools in clinical practice. \nRegister.
URL:https://oncodaily.com/event/car-t-423761
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ASTCT.webp
ORGANIZER;CN="American Society for Transplantation and Cellular Therapy (ASTCT)":MAILTO:info@astct.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251211
DTSTAMP:20260405T134638
CREATED:20251123T193232Z
LAST-MODIFIED:20251123T193250Z
UID:10000395-1765324800-1765411199@oncodaily.com
SUMMARY:ESMO Virtual Journal Club: December 2025
DESCRIPTION:The ESMO Virtual Journal Club: December 2025 is a one-hour virtual educational event exclusively for ESMO Members\, scheduled for Wednesday\, December 10\, 2025\, at 18:30 CET. \nChaired by Dr. Anna Campbell\, the Journal Club aims to enhance the understanding and application of the latest research in oncology by focusing on and critically evaluating two newly published studies: “Structured Exercise after Adjuvant Chemotherapy in Colon Cancer (CHALLENGE)” and “Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.” Live attendees will receive a certificate of attendance and 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-virtual-journal-club-415070
LOCATION:
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-1-1.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251214
DTSTAMP:20260405T134638
CREATED:20251012T222101Z
LAST-MODIFIED:20251012T222112Z
UID:10000277-1765324800-1765670399@oncodaily.com
SUMMARY:AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers - Knowledge Gaps and Research Opportunities
DESCRIPTION:This AACR Special Conference in Cancer Research will be held December 10–13\, 2025\, in Montreal\, Quebec\, Canada. \nThe meeting is designed as an in-person event\, with all presentations delivered live\, though the content will later be made available on demand. \nThe scientific program covers topics such as epidemiology of early-onset cancer\, mechanisms (metabolic\, exogenous\, endogenous)\, detection and screening\, interception strategies\, and global disparities in early-onset cancers. \nThis conference provides a forum for researchers\, clinicians\, and public health professionals to identify knowledge gaps and research opportunities in the rapidly evolving field of early-onset cancers. The sessions are structured to encourage cross-disciplinary dialogue and to spark ideas that can advance understanding and intervention strategies for cancers manifesting at younger ages. \nYou can find more posts featuring AACR on OncoDaily.
URL:https://oncodaily.com/event/aacr-389726
LOCATION:615 Chestnut Street\, 17th Floor\, Philadelphia\, PA 19106-4404\, USA\, 615 Chestnut Street\, 17th Floor\, Philadelphia\, PA 19106-4404\, USA\, Philadelphia\, PA\, 19106-4404\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/1757608291472.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251209
DTEND;VALUE=DATE:20251213
DTSTAMP:20260405T134638
CREATED:20251015T210634Z
LAST-MODIFIED:20251210T102007Z
UID:10000281-1765238400-1765583999@oncodaily.com
SUMMARY:San Antonio Breast Cancer Symposium (SABCS) 2025
DESCRIPTION:The San Antonio Breast Cancer Symposium (SABCS) 2025 will be held from December 9–12\, 2025\, at the Henry B. González Convention Center in San Antonio\, Texas\, USA. Recognized globally as one of the leading conferences in breast cancer research and treatment\, SABCS provides an unparalleled forum for the presentation and discussion of the latest scientific advances in both experimental biology and clinical care of breast cancer. \nThe symposium brings together basic scientists\, clinicians\, and healthcare professionals from around the world to foster collaboration and exchange of knowledge that drives progress in breast cancer prevention\, diagnosis\, and therapy. With its comprehensive program of plenary lectures\, case discussions\, and abstract presentations\, SABCS 2025 will continue its tradition of promoting excellence and innovation in breast cancer research and patient care. \nYou can find more posts featuring SABCS25 on OncoDaily.
URL:https://oncodaily.com/event/san-antonio-391265
LOCATION:SABCS\, Henry B. González Convention Center\, 900 E. Market Street\, San Antonio\, Texas 78205\, San Antonio\, TX\, 78205\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/SABCS-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251208
DTEND;VALUE=DATE:20251210
DTSTAMP:20260405T134638
CREATED:20251130T151257Z
LAST-MODIFIED:20251130T151257Z
UID:10000426-1765152000-1765324799@oncodaily.com
SUMMARY:ESMO Preceptorship on NSCLC and SCLC 2025: Singapore
DESCRIPTION:The ESMO Preceptorship on NSCLC and SCLC 2025 in Singapore\, taking place from 8 December 2025 to 9 December 2025\, brings together oncology professionals to explore best practices in managing non-small-cell and small-cell lung cancer across all stages. \nThe programme covers the latest in targeted therapies\, actionable driver alterations\, immune checkpoint blockade\, novel immunotherapies\, and systemic treatment of SCLC and pleural mesothelioma. Accredited with 10 ESMO-MORA category 1 points\, the preceptorship offers participants hands-on learning\, expert insights\, and a travel grant for non-local attendees to support participation.
URL:https://oncodaily.com/event/418939
LOCATION:The Orchard Singapore Hotel\, 442 Orchard Road\, Singapore\, 238879\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-2025-11-30T191149031-Picsart-AiImageEnhancer.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251208
DTEND;VALUE=DATE:20251209
DTSTAMP:20260405T134638
CREATED:20251222T214028Z
LAST-MODIFIED:20251222T214043Z
UID:10000519-1765152000-1765238399@oncodaily.com
SUMMARY:10 Years of the the National Cancer Institute of Luxembourg
DESCRIPTION:Celebrating 10 Years of the NCI: an evening to celebrate a decade of commitment\, the National Cancer Institute of Luxembourg hosted a milestone anniversary event on December 8\, 2025. \nThe evening highlighted the INC’s evolution into a central national coordination body and its role in integrating Luxembourg into European Comprehensive Cancer Centre (CCC) networks. Discussions emphasized the future of the national cancer ecosystem\, focusing on patient-centered clinical networks\, robust data infrastructures\, and the essential pillars of research\, education\, and public involvement to ensure sustainable progress in oncology for the years ahead. \nRead further.
URL:https://oncodaily.com/event/national-cancer-institute-432805
LOCATION:National Cancer Institute of Luxembourg\, Rue du Kiem 153-155 C\, Strassen/Luxembourg City\, Luxembourg District\, L-8030\, Luxembourg
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/NCI.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251207
DTEND;VALUE=DATE:20251208
DTSTAMP:20260405T134638
CREATED:20251128T232537Z
LAST-MODIFIED:20251128T232553Z
UID:10000417-1765065600-1765151999@oncodaily.com
SUMMARY:Japan TeamOncology Workshop (4th Team Science Workshop)
DESCRIPTION:The Japan TeamOncology Workshop (4th Team Science Workshop) is a two-part educational program focusing on promoting patient-centered\, multidisciplinary cancer care. \nThe first part is an online session via Zoom on Sunday\, December 7\, 2025\, from 8:00 a.m. to 4:30 p.m. (JST). \nThe second part is an in-person session held over three days: Saturday\, January 10\, Sunday\, January 11\, and Monday\, January 12\, 2026\, at the National Center for Global Health and Medicine in Shinjuku-ku\, Tokyo\, Japan. \nThe workshop\, now in its 24th year\, convenes oncology care professionals from Japan and across Asia to enhance their leadership and communication skills through didactic lectures\, interactive small group discussions\, and project-based learning (PBL)\, with a special emphasis on Psychological Safety and Equity\, Diversity\, and Inclusion.
URL:https://oncodaily.com/event/japan-teamoncology-workshop-418146
LOCATION:National Center for Global Health and Medicine\, 1-chōme-21-1 Toyama\, Shinjuku City\, Tokyo\, 162-8655\, Japan
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/jtop_4th_workshop_banner_ASCO-2.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251206
DTEND;VALUE=DATE:20251211
DTSTAMP:20260405T134638
CREATED:20251020T192031Z
LAST-MODIFIED:20251020T192639Z
UID:10000272-1764979200-1765411199@oncodaily.com
SUMMARY:ON-COLLAB Brazil - International Workshop on Oncology Research Methods
DESCRIPTION:The International Workshop on Oncology Research Methods (ON-COLLAB Brazil) is a five-day\, fully funded immersive program organized by the Brazilian Ministry of Health\, the University Hospitals Company (EBSERH) and 45 University Hospitals Network. \nTaking place December 5-10\, 2025\, in Atibaia\, São Paulo\, Brazil\, the workshop aims to strengthen research capacity in oncology by connecting national and international experts with early- and mid-career healthcare professionals. \nDesigned for clinicians\, residents\, and researchers working in oncology and related fields\, ON-COLLAB focuses on developing and refining participants’ clinical and applied research project proposals. Through lectures\, hands-on group work\, and mentorship from global leaders affiliated with ASCO\, EORTC\, AORTIC\, and Nature Cancer Reviews\, attendees will enhance their knowledge in research design\, data analysis\, and scientific writing. \nParticipation in the workshop is free of charge\, with accommodation and meals provided. A total of 24 professionals will be selected\, and notably\, one-third of places are reserved for applicants from Portuguese-speaking African countries and Latin America. \nRegistration runs from October 9-29\, 2025\, and applicants are encouraged to submit a preliminary oncology research proposal to be refined during the program. \nFor inquiries\, contact on-collab@ebserh.gov.br. \n \nRead more about the event on OncoDaily.
URL:https://oncodaily.com/event/on-collab-brazil-389226
LOCATION:Hotel Fazenda Hípica Atibaia – SP / Brazil\, Estrada Guaxinduva\, 1145\, Atibaia\, São Paulo (SP)\, 12940-000\, Brazil
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/ON-COLLAB.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251206
DTEND;VALUE=DATE:20251210
DTSTAMP:20260405T134638
CREATED:20251204T145340Z
LAST-MODIFIED:20251204T145352Z
UID:10000448-1764979200-1765324799@oncodaily.com
SUMMARY:67th ASH Annual Meeting and Exposition
DESCRIPTION:The 67th ASH Annual Meeting and Exposition\, the world’s most comprehensive event in classical and malignant hematology\, is scheduled to take place virtually and in-person from December 6–9\, 2025. The in-person component will be held at the Orange County Convention Center in Orlando\, Florida. \nHosted by the American Society of Hematology\, the meeting attracts over 30\,000 attendees and features more than 5\,000 novel abstracts\, providing a world-class educational and networking experience for researchers\, clinicians\, trainees\, and industry professionals. Registration is now open for ASH members\, non-members\, groups\, exhibitors\, and media.
URL:https://oncodaily.com/event/ash-annual-meeting-421409
LOCATION:Orange County Convention Center\, 9860 Universal Blvd\, Orlando\, FL\, 32819-8706\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ASH.webp
ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org
END:VEVENT
END:VCALENDAR